Xtant Medical Hldgs Q2 EPS $(0.02), Inline, Sales $20.23M Beat $19.50M Estimate
Portfolio Pulse from Benzinga Newsdesk
Xtant Medical Hldgs (AMEX:XTNT) reported Q2 earnings per share of $(0.02), in line with analyst expectations. The company's quarterly sales of $20.23 million exceeded the analyst consensus estimate of $19.50 million by 3.75%, marking a 32.43% increase from the same period last year.
August 01, 2023 | 11:19 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Xtant Medical's Q2 earnings met analyst expectations, while sales exceeded estimates and showed significant YoY growth. This could potentially boost investor confidence.
Xtant Medical's earnings were in line with expectations, which is generally a positive sign. More importantly, their sales not only beat estimates but also showed a significant YoY increase. This indicates strong performance and could potentially lead to a positive impact on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100